Protocol Development Module 02 From

Media Summary: Understand how research proposals are converted into detailed clinical trial Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global

Protocol Development Module 02 From - Detailed Analysis & Overview

Understand how research proposals are converted into detailed clinical trial Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Protocol Development Applying Research to Practice This lecture is part of the NIH Principles of Clinical Pharmacology Course which is an online lecture series covering the ... This lecture is part of the NIH Clinical and Translational Research Summer Course which provides an online opportunity for ...

Photo Gallery

Protocol Development Module 02 From Proposal to Protocol

Module 2 Part 1 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

Module 2 Part 2 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

MIDD Training Module 2 – Part Two

Protocol Design & Development: What You Need to Know to Ensure a Successful Study

MIDD Training Module 2 – Part One

Clinical Trials and Protocol Development

Protocol MODULE 2 Part A

Beginner-level workshop on “Network Pharmacology” on 5th July 2026 (Day 4)

Protocol Development Applying Research to Practice

Protocol MODULE 2 Part I

Introduction to Module 2 with Dr. Anne Zajicek

View Detailed Profile

Protocol Development Module 02 From Proposal to Protocol

Protocol Development Module 02 From Proposal to Protocol

Understand how research proposals are converted into detailed clinical trial

Module 2 Part 1 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

Module 2 Part 1 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

Module 2

Module 2 Part 2 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

Module 2 Part 2 Study Design & Protocol Development Research Methodology Webinar Series (2nd Ed)

Module 2

MIDD Training Module 2 – Part Two

MIDD Training Module 2 – Part Two

Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global

Protocol Design & Development: What You Need to Know to Ensure a Successful Study

Protocol Design & Development: What You Need to Know to Ensure a Successful Study

Solid

MIDD Training Module 2 – Part One

MIDD Training Module 2 – Part One

Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global

Clinical Trials and Protocol Development

Clinical Trials and Protocol Development

Video Scribe Project.

Protocol MODULE 2 Part A

Protocol MODULE 2 Part A

Protocol MODULE 2 Part A

Beginner-level workshop on “Network Pharmacology” on 5th July 2026 (Day 4)

Beginner-level workshop on “Network Pharmacology” on 5th July 2026 (Day 4)

Creation and analysis of network.

Protocol Development Applying Research to Practice

Protocol Development Applying Research to Practice

Protocol Development Applying Research to Practice

Protocol MODULE 2 Part I

Protocol MODULE 2 Part I

Protocol MODULE 2 Part I

Introduction to Module 2 with Dr. Anne Zajicek

Introduction to Module 2 with Dr. Anne Zajicek

This lecture is part of the NIH Principles of Clinical Pharmacology Course which is an online lecture series covering the ...

Presentation 6 - Protocol Development and Implementation - Tracy Miller and Stacy Kopka

Presentation 6 - Protocol Development and Implementation - Tracy Miller and Stacy Kopka

This lecture is part of the NIH Clinical and Translational Research Summer Course which provides an online opportunity for ...